| From animal models to human disease: a genetic approach for personalized medicine in ALS V Picher-Martel, PN Valdmanis, PV Gould, JP Julien, N Dupré Acta neuropathologica communications 4, 1-29, 2016 | 195 | 2016 |
| Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia L Renaud, V Picher-Martel, P Codron, JP Julien Acta neuropathologica communications 7, 1-11, 2019 | 104 | 2019 |
| Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells V Picher-Martel, K Dutta, D Phaneuf, G Sobue, JP Julien Molecular brain 8, 1-14, 2015 | 67 | 2015 |
| Transmission of ALS pathogenesis by the cerebrospinal fluid PS Mishra, H Boutej, G Soucy, C Bareil, S Kumar, V Picher-Martel, ... Acta neuropathologica communications 8 (1), 65, 2020 | 37 | 2020 |
| The occurrence of FUS mutations in pediatric amyotrophic lateral sclerosis: a case report and review of the literature V Picher-Martel, F Brunet, N Dupré, N Chrestian Journal of child neurology 35 (8), 556-562, 2020 | 29 | 2020 |
| Neuronal Expression of UBQLN2P497H Exacerbates TDP-43 Pathology in TDP-43G348C Mice through Interaction with Ubiquitin V Picher-Martel, L Renaud, C Bareil, JP Julien Molecular Neurobiology 56, 4680-4696, 2019 | 28 | 2019 |
| Current and promising therapies in autosomal recessive ataxias V Picher-Martel, N Dupre CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 17 | 2018 |
| Targeting TDP-43 pathology alleviates cognitive and motor deficits caused by chronic cerebral hypoperfusion SS Thammisetty, L Renaud, V Picher-Martel, YC Weng, F Calon, S Saikali, ... Neurotherapeutics 18 (2), 1095-1112, 2021 | 11 | 2021 |
| Whole-exome sequencing identifies homozygous mutation in TTI2 in a child with primary microcephaly: a case report V Picher-Martel, Y Labrie, S Rivest, B Lace, N Chrestian BMC neurology 20, 1-6, 2020 | 10 | 2020 |
| Case report: acute necrotizing encephalopathy following COVID-19 vaccine MR Bensaidane, V Picher-Martel, F Émond, G De Serres, N Dupré, ... Frontiers in Neurology 13, 872734, 2022 | 8 | 2022 |
| CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS V Picher-Martel, C Magnussen, M Blais, T Bubela, S Das, A Dionne, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (1-2), 33-39, 2023 | 6 | 2023 |
| SMALED2 with BICD2 gene mutations: Report of two cases and portrayal of a classical phenotype V Picher-Martel, C Morin, D Brunet, A Dionne Neuromuscular Disorders 30 (8), 669-673, 2020 | 5 | 2020 |
| Distinct plasma immune profile in ALS implicates sTNFR-II in pAMPK/leptin homeostasis V Picher-Martel, H Boutej, A Vézina, P Cordeau, H Kaneb, JP Julien, ... International Journal of Molecular Sciences 24 (6), 5065, 2023 | 4 | 2023 |
| Changes in Leptin, CCL16 and sTNF-RII as a Distinctive Plasma Immune Profile in Patients with Fast Progressing ALS (1276) V Picher-Martel, H Boutej, P Cordeau, H Kaneb, JP Julien, A Genge, ... Neurology 96 (15 Supplement), 2021 | 1 | 2021 |
| Low expression of mutant Ubiquilin-2 exacerbates ALS/FTD features in a TDP-43 mouse model (P4. 431) V Picher-Martel, JP Julien Neurology 90 (15 Supplement), 2018 | 1 | 2018 |
| Dysregulation of Adipocyte Response in Amyotrophic Lateral Sclerosis: Developing the Humanized in Vitro Model System to Screen for Immuno-metabolic Molecular Signatures (P5-11.001) V Alexandre, V Picher-Martel, H Boutej, A Genge, N Dupre, J Kriz Neurology 102 (17_supplement_1), 2985, 2024 | | 2024 |
| Chronically activated microglia in ALS gradually lose their immune functions and develop unconventional proteome R Barreto‐Núñez, LC Béland, H Boutej, V Picher‐Martel, N Dupré, ... Glia, 2024 | | 2024 |
| Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2 P Gonzalez-Perez, ES D'Ambrosio, V Picher-Martel, K Chuang, WS David, ... Neurology: Genetics 9 (3), e200073, 2023 | | 2023 |
| GP. 2 Changes in Leptin, CCL16 and sTNF-RII as a distinctive plasma immune profile in patients with fast progressing ALS V Picher-Martel, H Boutej, P Cordeau, H Kaneb, J Julien, A Genge, ... Canadian Journal of Neurological Sciences 48 (s3), S12-S12, 2021 | | 2021 |
| GP. 02 Neuronal expression of Ubiqulin-2 mutant exacerbates TDP-43 aggregation in ALS mouse mode V Picher-Martel, L Renaud, J Julien Canadian Journal of Neurological Sciences 46 (s1), S6-S6, 2019 | | 2019 |
